This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Antigenically Modified Human Pluripotent Stem Cells Generate Antigen-Presenting Dendritic Cells
Scientific Reports Open Access 16 October 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DeFrancesco, L. Landmark approval for Dendreon's cancer vaccine. Nat Biotechnol 28, 531–532 (2010). https://doi.org/10.1038/nbt0610-531
Issue Date:
DOI: https://doi.org/10.1038/nbt0610-531
This article is cited by
-
Precision immunomodulation with synthetic nucleic acid technologies
Nature Reviews Materials (2019)
-
Antigenically Modified Human Pluripotent Stem Cells Generate Antigen-Presenting Dendritic Cells
Scientific Reports (2015)
-
Sipuleucel-T (Provenge®)—Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention
BioDrugs (2015)
-
Dendreon bankrupt
Nature Biotechnology (2014)
-
Giving Oncolytic Vaccinia Virus More BiTE
Molecular Therapy (2014)